Published online Jan 21, 2016. doi: 10.3748/wjg.v22.i3.1078
Peer-review started: March 19, 2015
First decision: June 25, 2015
Revised: July 6, 2015
Accepted: November 13, 2015
Article in press: November 13, 2015
Published online: January 21, 2016
Processing time: 273 Days and 2.9 Hours
Core tip: The gut microbiota plays an important role in the pathogenesis and complications of inflammatory bowel disease. Antibiotics may influence the course of inflammatory bowel disease by decreasing concentrations of bacteria in the gut lumen and altering the composition of intestinal microbiota. In Crohn’s disease, antibiotics may have a modest effect in decreasing disease activity and achieving remission, are more effective in patients with disease involving the colon, and are useful in the treatment of suppurative complications. Data is more sparse and less conclusive for the treatment of ulcerative colitis, though there might be some benefit in antibiotic treatment. Side effects, the risk of Clostridium dificile infection, and increasing antibiotic resistance should be considered. Further studies are needed to define the role of antibiotic treatment in inflammatory bowel diseases.
